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Reactive oxygen species as glucose signaling molecules in mes- stress is defined as a tissue injury induced by increase in
angial cells cultured under high glucose. reactive oxygen species (ROS) such as hydrogen perox-
Background. Oxidative stress is one of the important media- ide (H2O2), superoxide anion (O2x2), and hydroxyl radicaltors of vascular complications in diabetes including nephrop-
(xOH) and is one of the proposed mechanisms involvedathy. High glucose (HG) generates reactive oxygen species
in diabetic complications [3–5]. A pathogenic role of(ROS) as a result of glucose auto-oxidation, metabolism, and
formation of advanced glycosylation end products. The concept ROS in diabetes is strongly supported by the observations
of ROS-induced tissue injury has recently been revised with that antioxidants suppress high glucose (HG)-induced ex-
the appreciation of new roles for ROS in signaling pathways tracellular matrix (ECM) protein synthesis in mesangialand gene expression.
cells [6–8] and prevent glomerular and renal hypertrophy,Methods and Results. High glucose rapidly generated dichloro-
albuminuria, and glomerular expression of transformingfluorescein-sensitive cytosolic ROS in rat and mouse mesangial
cells. Neither l-glucose nor 3-O-methyl-d-glucose increased growth factor-b1 (TGF-b1) and ECM in experimental
cytosolic ROS and cytochalasin B, an inhibitor of glucose trans- diabetic animals [9–12], and that vitamin E normalizes
porter, effectively inhibited HG-induced ROS generation, sug- glomerular hyperfiltration in human diabetes [13].gesting that glucose uptake and subsequent metabolism are
Reactive oxygen species have been considered cyto-required in HG-induced cytosolic ROS generation. H2O2 up-
regulated fibronectin mRNA expression and protein synthesis; toxic to a given tissue or cell. However, recent evidence
this up-regulation was effectively inhibited by protein kinase suggests that ROS may be an integral component of
C (PKC) inhibitor or by depletion of PKC. The HG-induced membrane receptor signaling in mammalian cells, in that
generation of ROS was, in turn, related to activation of PKC
ROS fulfill the important prerequisites for intracellularand transcription factors nuclear factor-kB (NF-kB) and activa-
messengers [14]. In this context, production of ROS hastor protein-1 (AP-1) as well as to the up-regulation of trans-
forming growth factor-b1 (TGF-b1), fibronectin mRNA ex- been detected in various cells stimulated by cytokines,
pression and protein synthesis, because antioxidants effectively growth factors, seven transmembrane receptor agonists,
inhibited HG-induced PKC, NF-kB, AP-1 activation, and and phorbol ester as summarized in Table 1 [15–29]. In
TGF-b1 and fibronectin expression in mesangial cells cultured
addition, administration of ROS mimics the effects ofunder HG.
given external stimuli (first messenger), generation ofConclusions. Although signal transduction pathways linking
HG, ROS, PKC, transcription factors, and extracellular matrix ROS in response to external stimuli is related to the
(ECM) protein synthesis in mesangial cells have not been fully activation of other signal transduction molecules such as
elucidated, the current data provide evidence that ROS gener- protein kinases, cytosolic Ca21, and transcription factors,
ated by glucose metabolism may act as integral signaling mole-
and antioxidants effectively ameliorate altered cell phys-cules under HG as in other membrane receptor signaling.
iology in response to external stimuli.
In this review, we propose the hypothesis that ROS
generated by HG may act as glucose signaling moleculesHyperglycemia is the main determinant of initiation
in diabetic nephropathy using mesangial cells culturedand progression of diabetic microvascular complications
under HG.including nephropathy in both insulin-dependent [1] and
non-insulin-dependent [2] diabetes mellitus. Oxidative
GENERATION OF REACTIVE OXYGEN
SPECIES IN MESANGIAL CELLS CULTURED1 Current address: Dr. Hunjoo Ha, Hyonam Kidney Laboratory, Soon
Chun Hyang University, Seoul 140-752, Korea. UNDER HIGH GLUCOSE
We recently visualized dichlorofluorescein (DCF)-Key words: extracellular matrix, protein kinase C, nuclear factor-kB,
activator protein-1. sensitive ROS generation in rat and mouse mesangial
cells cultured under HG by a confocal microscopy asÓ 2000 by the International Society of Nephrology
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Table 1. Reactive oxygen species as second messenger
Stimuli ROS Response Cell type Reference
Ang II O22x/H2O2 Vascular tone VSMC 18,24
p27Kip1 hypertrophy RTEC 29
EGF H2O2 Tyrosine phosphorylation A431 cell 25,27
IL-1 O22x/H2O2 JNK, c-jun Chondrocyte 16
Fibroblast 23
Insulin H2O2 Glucose transport
Lipid synthesis Adipocyte 15
LPA H2O2 MAPK HeLa 20
PDGF H2O2 MAPK, DNA synthesis
Chemotaxis VSMC 21
PMA H2O2 Tyrosine phosphorylation Macrophage 26
Keratinocyte 17
Phosphatidic acid H2O2 Ca21 Fibroblast 28
TGF-b H2O2 egr-1 Osteoblast 19
Cell cycle arrest Fibroblast 22
TNF-a O22x/H2O2 JNK, c-fos, c-jun Chondrocyte 16
Fibroblast 23
Abbreviations are: Ang II, angiotensin II; VSMC, vascular smooth muscle cells; EGF, epidermal growth factor; IL-1, interleukin-1; JNK, C-Jun-N-terminal kinase;
LPA, lysophosphatidic acid; MAPK, mitogen-activated protein kinases; PDGF, platelet-derived growth factor; PMA, phorbol myristate acetic acid; TGF-b, transforming
growth factor-b; TNF-a, tumor necrosis factor-a.
Fig. 1. HG generates dichlorofluorescein-sensitive reactive oxygen species in mesangial cells. Synchronized quiescent mesangial cells grown on
coverglass were incubated with 5.6 or 30 mmol/L glucose for 1 hour or with 100 mmol/L H2O2 for 15 min, washed with Dulbecco’s phosphate-buffered
saline and incubated in the dark for 5 minutes in Krebs-Ringer solution containing 5 mmol/L 5-(and-6)-chloromethyl-29,79-dichlorodihydrofluorescein
diacetate. Culture dishes were transferred to a Leica DM IRB/E inverted microscope, equipped with 320 Fluotar objective and Leica TCS NT
confocal attachment and the ROS generation was visualized.
shown in Fig. 1 (abstract; Ha et al, J Am Soc Nephrol regulatory mechanisms may operate in HG-induced
ROS generation in different cell types or species. Inas-10:A3452, 1999). High glucose induced DCF-sensitive
cytosolic ROS in as early as 15 minutes and gradually much as dichlorofluorescin diacetate enters into cells
and produces DCF, which fluoresces when it reacts withincreased up to 4 hours, in contrast to control glucose.
Unlike d-glucose, neither 25 mmol/L l-glucose nor 3-O- hydroperoxides or H2O2 [31, 32] and given that catalase
effectively inhibits HG-induced ROS generation, H2O2methyl-d-glucose induced cytosolic ROS generation. In
addition, a glucose transporter inhibitor cytochalasin B appears to be the main ROS generated by HG in mesan-
gial cells. Catalase is a 60 kD protein that forms a homo-effectively inhibited HG-induced cytosolic ROS. These
results suggest that glucose uptake and subsequent me- dimer in solution and thus does not simply diffuse into
cells. Energy-dependent and perhaps receptor-mediatedtabolism, but not glucose auto-oxidation, are required
for HG-induced ROS generation in mesangial cells. 3- processes have been suggested in cellular uptake of cata-
lase in vascular smooth muscle cells [21]. HG-inducedO-methyl-d-glucose is a glucose analog that enters into
the cell but is not metabolized. Lack of effect of 3-O- H2O2 generation agrees with the conclusions of a previ-
ous study that demonstrated increased H2O2 in mesangialmethyl-d-glucose on cytosolic ROS generation in rat and
mouse mesangial cells is different from the observation cells cultured under HG [33]. At present, little is known
about the mechanisms of HG-induced H2O2 generationin human endothelial cells [30], suggesting that different
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or target molecules of H2O2. These areas require future involved in HG-induced glomerular injury [42] and pro-
studies. duces ROS and subsequent lipid peroxidation [45–47].
Advanced glycation end products (AGE) are pro- Conversely, ROS also activate PKC. H2O2 activates PKC
duced by a process involving nonenzymatic modification through direct or indirect activation of phospholipase D,
of proteins by physiologic sugars and their reactive dicar- which hydrolyzes phosphatidylcholine to produce diacyl-
bonyls such as glyoxal, 3-deoxyglucosone, and methylgly- glycerol (DAG) [48], and through de novo synthesis of
oxal and are independent risk factors for diabetic nephrop- DAG resulting from inhibition of glyceraldehyde phos-
athy [34–36]. In addition to altered protein structure and phate dehydrogenase [49]. In addition, activation of PKC
function induced by AGE, AGE bind to cell surface is sensitively regulated through redox changes in sulfhy-
receptors and initiate ROS production, which activates dryl groups of cysteine-rich regions of PKC [50, 51]. All
expression of gene products including cytokines and hor- these observations suggest facilitative interaction be-
mones [37, 38]. Although the production of ROS in mes- tween ROS and PKC under hyperglycemia. In fact, struc-
angial cells in response to AGE has not been demon-
turally different antioxidants suppressed an increase instrated, HG may generate cytosolic ROS directly through
PKC in rat mesangial cells [52]. We have reported thatglucose metabolism and indirectly through AGE.
inhibition of PKC effectively blocked not only phorbol
ester-induced but also HG-and H2O2-induced fibronectin
H2O2-INDUCED FIBRONECTIN mRNA expression and protein synthesis by mesangial
UP-REGULATION IN MESANGIAL CELLS cells as shown in Fig. 2.
HG-induced ROS generation appears to play a major MAPK consist of groups of serine–specific kinases that
role in mesangial ECM expansion, which is the major are activated by extracellular stimuli through dual phos-
pathologic feature in diabetic nephropathy [39], because phorylation at conserved threonine and tyrosine resi-
HG-induced collagen production in cultured rat mesan- dues. Three major groups of MAPK exist; the extracellu-
gial cells was effectively prevented by two antioxidants, lar signal-regulated kinases (ERK), the c-Jun N-terminal
taurine [6] and vitamin E [7]. We also demonstrated kinases (JNK), and the p38 kinases. Understanding of
that rebamipide and dimethylthiourea at concentrations their roles in cell physiology continues to evolve and all
inhibiting HG-induced lipid peroxidation blocked fi- three MAPK play essential roles in the signal transduc-
bronectin mRNA expression and protein synthesis by tion of many biologic events such as cell growth, differ-
mouse mesangial cells cultured under HG [8]. In addi- entiation, and apoptosis. Tomlinson et al [43] recentlytion, we earlier reported that H2O2 at 100 mmol/L signifi- proposed MAPK as glucose transducers for diabeticcantly increased fibronectin mRNA expression and pro-
complications. Activation of an MAPK cascade in dia-tein synthesis by murine mesangial cells as shown in Fig.
betic glomeruli and mesangial cells cultured under HG2 (abstract; Ha and Kim, Nephrology 3(Suppl 1):A736,
has been reported [44]. Given that MAPK activation1997).
was observed 5 days after stimulation with HG in the
study cited, other HG-induced cytokines and growth fac-
TARGET MOLECULES ON WHICH HIGH tors in addition to HG itself may have augmented MAPK
GLUCOSE-INDUCED REACTIVE OXYGEN activation. For example, TGF-b1, the final mediator of
SPECIES ACT TO PROPAGATE THE SIGNAL HG-induced ECM accumulation [53], also uses MAPK
IN MESANGIAL CELLS
as its signaling pathway as reviewed by Choi et al and
As has been reviewed extensively [14, 40, 41], the Kikkawa elsewhere in this Supplement. Because ROS
growing medical literature from disciplines outside of are the major stimuli activating MAPK in various cells
diabetes research show that ROS can activate most [40, 41, 54], it would be interesting to know whether
known signal transduction pathways. In diabetes, protein antioxidants can prevent hyperglycemia-induced MAPK
kinase C (PKC) [42] and, more recently, mitogen-acti- activation.
vated protein kinases (MAPK) [43, 44] have been shown
Because it remains unclear which transcription factorsto be activated and mediate HG-induced tissue injury.
are ultimately activated by HG-induced ROS generationIn addition, HG may transduce messages to the nucleus
and thereby lead to diabetic glomerular injury, we exam-leading to gene transcription by a class of proteins called
ined whether HG-induced ROS activate NF-kB andtranscription factors that bind to specific DNA sequences
AP-1 by electrophoretic mobility shift assay (EMSA).to regulate RNA polymerase II activity. NF-kB and acti-
NF-kB is the first eukaryotic transcription factor shownvator protein (AP)-1 are well known redox sensitive
to respond directly to ROS [55, 56]. This transcriptiontranscription factors that activate the genes coding for
factor plays an important role in the regulation of genescytokines, growth factors, and ECM proteins [40, 41].
involved in immune and inflammatory process. AP-1,Target molecules on which ROS act to propagate the
a heterodimer of Fos and Jun proteins, controls genessignal determine the cell type–specific and diverse events
involved in cell growth. Previous studies demonstratedand outcomes.
Activation of PKC is one of the major mechanisms that AP-1 is activated by ROS [40, 41]. It is possible that
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Fig. 2. H2O2 up-regulates fibronectin mRNA expression and protein synthesis in mesangial cells through PKC activation. Synchronized quiescent
mesangial cells were stimulated with 30 mmol/L glucose, 100 mmol/L H2O2, or 100 nmol/L phorbol ester (PMA) in the presence or absence of
PKC inhibition. Calphostin C (100 nmol/L) was used to inhibit PKC. Endogenous PKC was depleted by preincubating cells with 100 nmol/L PMA
for 24 hours. (A) After 24 hours’ incubation for a given experimental condition, total RNA was isolated, electrophoresed, and transferred
onto nylon membranes. Northern blots were hybridized with 32P-labeled cDNA probes for fibronectin (FN) and glyceraldehyde-3-phosphate
dehydrogenase. Symbols are: h, no calphostin C; j, 100 nmol/L calphostin C. (B) Aliquots of mesangial cell–conditioned media were electrophoresed
under reducing conditions and transferred onto nitrocellulose membranes and Western blots were performed using the ECL detection system.
Autoradiographs were developed by exposing blots to radiographic films. Values were expressed as mean 6 standard error of four experiments.
Symbols are: h, no PKC depletion; j, PKC depletion. *P , 0.05 compared with control without PKC inhibition. †P , 0.05 compared with the
corresponding values without PKC inhibition.
the essential Cys residues of NF-kB, c-Fos, and c-Jun are ies are required. HG-induced NF-kB activation may be
involved in HG-induced monocyte chemotactic peptidetargets of ROS modification, so that this modification,
together with phosphorylation events, may be responsi- (MCP)-1 mRNA expression observed in human mesan-
gial cells [60]. The promotor region of MCP-1 contains anble for their signaling mechanisms [14].
As has been reported in endothelial and vascular NF-kB binding site [61] and MCP-1 mRNA expression is
regulated by NF-kB activation in mesangial cells [62].smooth muscle cells [30, 57–59], d-glucose induced NF-kB
activation in mesangial cells in a dose- and time-depen- In addition, Smad 7, an inhibitor of autoinduction of
TGF-b, is transcriptionally activated by p65 subunit ofdent manner and antioxidants effectively inhibited HG-
induced NF-kB activation, which suggests ROS as medi- NF-kB as reviewed by Bo¨ttinger in this Supplement.
HG-induced AP-1 activation demonstrated by EMSAators of HG-induced activation of transcription factors
(abstract; Ha et al, J Am Soc Nephrol 9:A3226, 1998). agrees with previous studies that reported increased ex-
pression of growth-related proto-oncogene c-fos and30 mmol/L d-glucose but not l-glucose rapidly (i.e., less
than 15 minutes) and continuously (up to 48 hours) acti- c-jun in mesangial cells cultured under HG [63] and in
the glomeruli from streptozotocin-induced diabetic ratsvated AP-1 compared with 5.6 mmol/L (control) glucose
(Fig. 3A,B). In addition, H2O2 activated both NF-kB [64]. The c-Fos and c-Jun proteins, along with other Jun
proteins, such as JunB and JunD, are members of the(data not shown) and AP-1 (Fig. 3C) in a dose-dependent
manner. AP-1 transcription factor family [65] and a heterodimeric
interaction between the two allows for binding to consen-The biological significance of NF-kB activation in MC
under HG, however, is still not known, and further stud- sus DNA sequences in the regulatory elements of certain
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Fig. 3. Reactive oxygen species activate acti-
vator protein-1 in mesangial cells cultured
under high glucose. Synchronized quiescent
mesangial cells were stimulated under given
experimental conditions. Nuclear proteins
were prepared and subjected to EMSA. (A)
Representative EMSA showing mesangial
AP-1 activation by d-glucose but not by l-glu-
cose. Mesangial cells were stimulated for 1
hour. (B) Time response of mesangial AP-1
activation. Mesangial cells were incubated
with 30 mmol/L (high) glucose or 5.6 mmol/L
(control) glucose for indicated periods. (C)
Effects of H2O2 on AP-1 activation in mesan-
gial cells.
Fig. 4. Proposed role of reactive oxygen spe-
cies as glucose signaling molecules in mesan-
gial cells. HG may increase cytosolic ROS di-
rectly through its metabolism and indirectly
through AGE formation. Facilitative interac-
tion occurs between ROS and PKC in hyper-
glycemia. ROS and PKC may activate MAPK
cascade and several transcription factors in-
cluding NF-kB and AP-1. It is also speculated
that the essential Cys residues of NF-kB, c-Fos,
and c-Jun can be modified by ROS and this
modification together with phosphorylation
events may be responsible for their signaling
mechanisms.
genes, called AP-1 and TPA responsive sites [66]. Be- AMELIORATION OF HIGH GLUCOSE-
INDUCED ALTERATIONS IN MESANGIALcause AP-1 consensus sites exist in the promotor regions
CELL BIOLOGY BY ANTIOXIDANTSof TGF-b1 [67], fibronectin [63], and laminin B genes
[63], it is possible that cytosolic ROS may up-regulate As summarized earlier in this paper, antioxidants ef-
TGF-b1, fibronectin, and laminin B expression through fectively prevented altered biology of mesangial cells
AP-1 activation in mesangial cells cultured under HG. cultured under HG. For example, antioxidants abolished
However, the relationships among ROS, AP-1 activity, HG-induced cytosolic ROS generation (abstract; Ha et
and ECM production under HG have not been fully al, J Am Soc Nephrol 10:A3452, 1999), PKC activation
[52], up-regulations of TGF-b1 [8, 52] and fibronectindefined and require future studies.
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